Sharp Aisi: plans to transfer 4.5% of Stanley's equity to Lechun Bio

[Sharp Aisi: plans to transfer 4.5% of Stanley's equity to Lechun Biotechnology]. Sharp Aisi announced that it intends to transfer 4.5% of its stake in Stanley Biotechnology (Hangzhou) Co., Ltd. to Shanghai Lechun Biotechnology Co., Ltd., with a transfer price of 12.6 million yuan.